Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration. (2019)
Attributed to:
Treatment of inflammation via activation of the mRNA-destabilising protein tristetraprolin
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.pharmthera.2019.05.016
PubMed Identifier: 31158394
Publication URI: http://europepmc.org/abstract/MED/31158394
Type: Journal Article/Review
Volume: 201
Parent Publication: Pharmacology & therapeutics
ISSN: 0163-7258